NeuroPace Inc. (NPCE)
NeuroPace Max Pain By Strike
NPCE trades at $8.35, 234.0% above the near-term max pain of $2.5 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$12.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
NeuroPace Max Pain By Expiry
Max pain for NPCE shows a downward trend from 12.5 to 2.5, indicating bearish sentiment or hedging activity. The 140% spread signals divergent expectations across timeframes. Levels distributed around 8.35. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2.5 | -5.85 (-70.06%) |
| Oct 17, 2025 | 2.5 | -5.85 (-70.06%) |
| Nov 21, 2025 | 12.5 | 4.15 (49.70%) |
| Dec 19, 2025 | 10 | 1.65 (19.76%) |
| Jan 16, 2026 | 8 | -0.35 (-4.19%) |
| Feb 20, 2026 | 7.5 | -0.85 (-10.18%) |